2012
DOI: 10.1002/ana.22621
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic devices for epilepsy

Abstract: Therapeutic devices provide new options for treating drug-resistant epilepsy. These devices act by a variety of mechanisms to modulate neuronal activity. Only vagus nerve stimulation, which continues to develop new technology, is approved for use in the United States. Deep brain stimulation (DBS) of anterior thalamus for partial epilepsy recently was approved in Europe and several other countries. Responsive neurostimulation, which delivers stimuli to one or two seizure foci in response to a detected seizure, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
82
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 111 publications
(83 citation statements)
references
References 112 publications
1
82
0
Order By: Relevance
“…However, patients diagnosed with other forms of epilepsy who do not benefit sufficiently from medication may be eligible for (cerebellar) DBS 47. Currently, the options for applying DBS are limited; only the anterior thalamic nucleus is currently described in the US Food and Drug Administration guidelines to treat intractable epilepsy, and although promising, the outcome is limited and can result in cognitive and emotional problems 72, 73. Given the powerful impact of CN stimulation on thalamocortical activity that is shown in the present study, we hypothesize that CN stimulation may also exert very positive effects in these other, more severe kinds of epilepsies.…”
Section: Discussionmentioning
confidence: 99%
“…However, patients diagnosed with other forms of epilepsy who do not benefit sufficiently from medication may be eligible for (cerebellar) DBS 47. Currently, the options for applying DBS are limited; only the anterior thalamic nucleus is currently described in the US Food and Drug Administration guidelines to treat intractable epilepsy, and although promising, the outcome is limited and can result in cognitive and emotional problems 72, 73. Given the powerful impact of CN stimulation on thalamocortical activity that is shown in the present study, we hypothesize that CN stimulation may also exert very positive effects in these other, more severe kinds of epilepsies.…”
Section: Discussionmentioning
confidence: 99%
“…This technique uses light-activated microbial proteins such as Channelrhodopsin 2 (ChR2), which depolarizes neurons when illuminated with blue light, or Halorhodopsin (NpHR), which hyperpolarizes neurons (21,28,29). Optogenetic approaches have been used in rodents to probe neuronal circuits for several neurological/neurodegenerative diseases, including Parkinson disease (30) and epilepsy (31). Recent studies have also used optogenetics to map functional organization after stroke (32)(33)(34)(35).…”
mentioning
confidence: 99%
“…The effect of structured auditory stimuli provides non-invasive galvanic cortex stimulation, which can reduce epileptiform activity. (32) To prove this hypothesis, researchers conducted a randomized study, which explored the effectiveness of music therapy for patients diagnosed with epilepsy. (33) Patients were exposed to Mozart's music every night for one year.…”
Section: Psychotherapeutic Optionsmentioning
confidence: 99%